Project Details
| Status | Active |
|---|---|
| Effective start/end date | 19/08/21 → 19/09/25 |
Funding
- Vertex Pharmaceuticals (Aust) Pty Ltd: A$5,767.00
A phase 3, Randomised,double-blind, controlled study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects with Cystic: Vertex Study Number : VX20-121-103
- Mulrennan, Siobhain (Investigator 01)